Contrast Media Market Size, Growth and Trends Analysis By Type (Iodinated Contrast Media and Gadolinium-Based Contrast Media), by Form (Tablet, Powder, Liquid and Paste), Procedures (X-ray/Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)), Application (Cardiovascular Disease, Oncology and Gastrointestinal Disorders), Route of Administration (Rectal, Oral and Injectable) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027
ID: MRFR/LS/0776-HCR | August 2022 | Region: Global | 90 Pages
Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL CONTRAST MEDIA MARKET, BY TYPE
6.1. Overview
6.2. Iodinated Contrast Media
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Gadolinium-based Contrast Media
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Microbubble Contrast Media
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Barium-based Contrast Media
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL CONTRAST MEDIA MARKET, BY FORM
7.1. Overview
7.2. Tablet
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Powder
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Liquid
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Paste
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL CONTRAST MEDIA MARKET, BY PROCEDURES
8.1. Overview
8.2. X-Ray/Computed Tomography (CT)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Magnetic Resonance Imaging (MRI)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Ultrasound
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION
9.1. Overview
9.2. Cardiovascular Disease
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3. Oncology
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4. Gastrointestinal Disorders
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.5. Neurological Disorders
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.6. Other Indications
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10. GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION
10.1. Overview
10.2. Rectal
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10.3. Oral
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10.4. Injectable
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
11. GLOBAL CONTRAST MEDIA MARKET, BY REGION
11.1. Overview
11.2. Americas
11.2.1. North America
11.2.1.1. US
11.2.1.2. Canada
11.2.2. Latin America
11.3. Europe
11.3.1. Western Europe
11.3.1.1. Germany
11.3.1.2. France
11.3.1.3. Italy
11.3.1.4. Spain
11.3.1.5. UK
11.3.1.6. Rest of Western Europe
11.3.2. Eastern Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Middle East & Africa
11.5.1. Middle East
11.5.2. Africa
12. COMPANY LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Contrast Media Market
12.5. Competitive Benchmarking
12.6. Leading Players in terms of Number of Developments in the Global Contrast Media Market
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix & Market Ratio
12.8.1. Sales & Operating Income 2020
12.8.2. Major Players R&D Expenditure 2020
12.9. Major Players Capital Market Ratio
13. COMPANY PROFILES
13.1. DAIICHI
13.1.1. Company Overview
13.1.2. Product Overview
13.1.3. Financial Overview
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. NANOSCAN IMAGING
13.2.1. Company Overview
13.2.2. Product Overview
13.2.3. Financial Overview
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Bayer AG
13.3.1. Company Overview
13.3.2. Product Overview
13.3.3. Financial Overview
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Bracco Diagnostic Inc
13.4.1. Company Overview
13.4.2. Product Overview
13.4.3. Financial Overview
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. GE Healthcare
13.5.1. Company Overview
13.5.2. Product Overview
13.5.3. Financial Overview
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Guerbet Group
13.6.1. Company Overview
13.6.2. Product Overview
13.6.3. Financial Overview
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Jodas Expoim
13.7.1. Company Overview
13.7.2. Product Overview
13.7.3. Financial Overview
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. Lantheus Medical Imaging Inc.
13.8.1. Company Overview
13.8.2. Product Overview
13.8.3. Financial Overview
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Magnus Health
13.9.1. Company Overview
13.9.2. Product Overview
13.9.3. Financial Overview
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. Spago Nanomedical AB
13.10.1. Company Overview
13.10.2. Product Overview
13.10.3. Financial Overview
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
13.11. Taejoon Pharm
13.11.1. Company Overview
13.11.2. Product Overview
13.11.3. Financial Overview
13.11.4. Key Developments
13.11.5. SWOT Analysis
13.11.6. Key Strategies
13.12. Others
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL CONTRAST MEDIA MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL CONTRAST MEDIA MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 7 GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 8 GLOBAL CONTRAST MEDIA MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: CONTRAST MEDIA MARKE, BY TYPE, 2020-2027 (USD MILLION)
TABLE 10 NORTH AMERICA: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 11 NORTH AMERICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 12 NORTH AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 13 NORTH AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 14 US: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 15 US: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 16 US: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 17 US: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 18 US: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 19 CANADA: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 20 CANADA: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 21 CANADA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 22 CANADA: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 23 CANADA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 24 LATIN AMERICA: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 25 LATIN AMERICA: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 26 LATIN AMERICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 27 LATIN AMERICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 28 LATIN AMERICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 29 EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 30 EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 31 EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 32 EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 33 EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 34 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 35 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 36 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 37 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 38 WESTERN EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 39 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 40 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 41 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 42 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 43 EASTERN EUROPE: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 44 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 45 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 46 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 47 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 48 ASIA-PACIFIC: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY FORM, 2020-2027 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2020-2027 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CONTRAST MEDIA MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CONTRAST MEDIA MARKET
FIGURE 4 GLOBAL CONTRAST MEDIA MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL CONTRAST MEDIA MARKET SHARE, BY FORM, 2020 (%)
FIGURE 6 GLOBAL CONTRAST MEDIA MARKET SHARE, BY PROCEDURES, 2020 (%)
FIGURE 7 GLOBAL CONTRAST MEDIA MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 8 GLOBAL CONTRAST MEDIA MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)
FIGURE 9 GLOBAL CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 AMERICAS: CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 NORTH AMERICA: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 EUROPE: CONTRAST MEDIA MARKET SHARE, BY REGION, 2020 (%)
FIGURE 13 WESTERN EUROPE: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 ASIA-PACIFIC: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 15 MIDDLE EAST & AFRICA: CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 16 GLOBAL CONTRAST MEDIA MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 17 DAIICHI.: KEY FINANCIALS
FIGURE 18 DAIICHI: SEGMENTAL REVENUE
FIGURE 19 DAIICHI: REGIONAL REVENUE
FIGURE 20 NANOSCAN IMAGING: KEY FINANCIALS
FIGURE 21 NANOSCAN IMAGING: SEGMENTAL REVENUE
FIGURE 22 NANOSCAN IMAGING: REGIONAL REVENUE
FIGURE 23 BAYER AG: KEY FINANCIALS
FIGURE 24 BAYER AG: SEGMENTAL REVENUE
FIGURE 25 BAYER AG: REGIONAL REVENUE
FIGURE 26 BRACCO DIAGNOSTIC INC: KEY FINANCIALS
FIGURE 27 BRACCO DIAGNOSTIC INC: SEGMENTAL REVENUE
FIGURE 28 BRACCO DIAGNOSTIC INC: REGIONAL REVENUE
FIGURE 29 GE HEALTHCARE: KEY FINANCIALS
FIGURE 30 GE HEALTHCARE: SEGMENTAL REVENUE
FIGURE 31 GE HEALTHCARE: REGIONAL REVENUE
FIGURE 32 GUERBET GROUP: KEY FINANCIALS
FIGURE 33 GUERBET GROUP: SEGMENTAL REVENUE
FIGURE 34 GUERBET GROUP: REGIONAL REVENUE
FIGURE 35 JODAS EXPOIM: KEY FINANCIALS
FIGURE 36 JODAS EXPOIM: SEGMENTAL REVENUE
FIGURE 37 JODAS EXPOIM: REGIONAL REVENUE
FIGURE 38 LANTHEUS MEDICAL IMAGING INC.: KEY FINANCIALS
FIGURE 39 LANTHEUS MEDICAL IMAGING INC.: SEGMENTAL REVENUE
FIGURE 40 LANTHEUS MEDICAL IMAGING INC.: REGIONAL REVENUE
FIGURE 41 MAGNUS HEALTH: KEY FINANCIALS
FIGURE 42 MAGNUS HEALTH: SEGMENTAL REVENUE
FIGURE 43 MAGNUS HEALTH: REGIONAL REVENUE
FIGURE 44 SPAGO NANOMEDICAL AB: KEY FINANCIALS
FIGURE 45 SPAGO NANOMEDICAL AB: SEGMENTAL REVENUE
FIGURE 46 SPAGO NANOMEDICAL AB: REGIONAL REVENUE
FIGURE 47 TAEJOON PHARM: KEY FINANCIALS
FIGURE 48 TAEJOON PHARM: SEGMENTAL REVENUE
FIGURE 49 TAEJOON PHARM: REGIONAL REVENUE
Contrast Media Market
The Contrast Media Market value of USD 4.96 Billion in 2018 and is projected to register a 3.9% CAGR over the forecast period.
$4.96 Billion
Market Size
3.9%
CAGR
North America
Dominating Region
2022 - 2030
Forecast Period
Segmentation
Key Players
- Bayer AG (Germany)
- Bracco Diagnostic Inc (US)
- DAIICHI (Japan)
- NANOSCAN IMAGING (US)
- Jodas Expoim (India)
- GE Healthcare (US)
- Guerbet Group (France)
- Lantheus Medical Imaging Inc (US)
- Taejoon Pharm (Korea)
- Magnus Health (US)
Drivers
- Increasing prevalence of cancer and cardiac disease
- Increasing patient pool increases the demand for medical imaging
- which boosts the contrast media market
Contrast Media Market Overview
In 2018, the Contrast Media Market was estimated to increase at USD 4.96 Billion. Further, the global market is expected to generate a 3.5% CAGR for the forecast period of 2025. Contrast media are extensively used to distinguish normal conditions from the abnormal conditions of the patients. Contrast media are also known as contrast agents. Before imaging the examination, the contrast agents are used as the chemical components that are introduced into the patient’s body to understand the health condition.
The global contrast media in radiology market has been segregated into procedures, type, form, route of administration, and application. If looking into the various regions of the global market, it has segmented into different countries. The American region of the Contrast Media Market has been further divided into Latin America and North America. Moreover, the Contrast Media Industry of North America has further sub-segmented into Canada and the US. The market of the European region has been classified into Eastern Europe and Western Europe. Moreover, Western Europe has been further sub-divided as the UK, Germany, France, Spain, Italy, and the rest of Western Europe. Along with that, the Contrast Media Market of the Asia-Pacific region has been classified into India, Japan, China, Australia, Latin Korea, and the rest of Asia-Pacific. Further, the Middle East & African region of the global market has been divided into the Middle East and African countries.
The MRI contrast agents market report highlighted the recent growth and developments of the global market. Recently, in November 2019, the Food and Drug Administration (FDA) of the US has approved GE Healthcare for intravenous use with the gadolinium macrocyclic-based and Clariscan (adulterate meglumine) anionic contrast agent injection. In addition, in September 2019, the Medrad Stellant Flex CT injection system was introduced by Bayer AG to manage contrast dose. Along with that, the products demands are increasing due to the purchasing power of the intended audience. These intended audiences are Hospitals and diagnostic centers, ambulatory surgery centers, medical device manufacturing companies, Academic centers, distributors and suppliers of medical devices, and Venture capitalists.
COVID-19 Impact Analysis
The global COIVID-19 has impacted the global Contrast Media Market due to the global lockdown in different regions. The people avoided visiting the health sectors for medical imaging, which has reduced the demand for the global market.
But the continuous efforts of the global key players have lifted the demands for the global market in the pandemic situation.
Contrast Media Market Dynamics
-
Major Drivers of the Market
The growing prevalence of cardiac disease, accidental cases, and cancer are increasing the requirements for medical imaging. This medical imaging is used especially to examine different stages of treatment for the patient. Hence, the increasing use of medical imaging is increasing the demand for the global Contrast Media Market and driving the growth of the global market.
Moreover, the key players are giving more focus on the growth driving factors to develop the products.
-
Opportunities for the Global Market
The demand for the global Market is increasing due to the different diagnostic imaging modalities, and improved diagnostic imaging services demand among the audiences, which is bringing lucrative opportunities for the global market.
Moreover, the marketing companies of the global Contrast Media Industry are introducing new advanced technologies and quality products with advanced features. This can bring more opportunities for the global market.
-
Restraints of Global Market
The major factors like side effects, allergic reactions, or adverse reactions such as diarrhea, stomach cramps, nausea, constipation, and vomiting might hamper the growth of the global Contrast Media Industry.
Hence, the global market is employing professional manufacturers to look into these major restraints.
-
Challenges for the Global Market
The global Contrast Media Industry might face challenges due to the rising cost and side effects.
Hence, the global key players are working on these emerging challenges to combat this in a very short period.
-
Cumulative Growth Analysis of the Global Market
If looking into the 2018 report, the global contrast media market has generated a higher contrast media market size, and further, it has aimed to achieve its goal of increasing more market size for the forecast period.
The regions like North America, European regions are contributing higher to the global Contrast Media Market, which shows the increasing regional growth will bring more opportunities for the global key players of the market.
Contrast Media Market Segmentation Overview
- By Type:
On the basis of type segment, the types of contrast media are gadolinium-based contrast media, iodinated contrast media, barium-based contrast media, and microbubble contrast media.
The different types of contrast media are having a different role in the contrast media market.
- By Form:
The global Market has been classified into liquid, tablet, powder, and paste based on the form segment.
These all forms are preferred by the intended audiences according to the requirements of the products.
- By Procedures:
Based on the procedures segment, the contrast media allergy market has been divided into magnetic resonance imaging (MRI), X-ray or computed tomography (CT), ultrasound, and others.
They discussed important procedures that are increasing the demands for the global Contrast Media Industry.
- By Applications:
On the basis of application segment, the Market has been classified into oncology, cardiovascular disease, neurological disorders, gastrointestinal disorders, and other indications.
Hence, the contrast media manufacturers are getting more opportunities with the increasing applications.
- By Route of Administration:
On the basis of route of administration segment, the Market has been classified into injectable, rectal, and oral.
Among these, the injectable route of administration is aimed to grow the global Contrast Media Industry.
Regional Analysis
The radiographic contrast media market has been divided into various regions such as the Americas, the Middle East & Africa, Europe, and Asia-Pacific. Among these, the American region is expected to rule the global contrast agents market due to the growing preferences for the diagnosis of people suffering and various health conditions like intestinal diseases, spinal injury, brain problems, cancer, and other diseases. Moreover, the growing demands for medical imaging are bringing scope for the global contrast media/contrast agent market.
The European region is predicted to register the Contrast Media Market in the second-largest position. This region is growing the product demands due to the growing healthcare expenditure, the presence of more medical device companies in the region, and the increasing economy of the region. Apart from that, the Asia-Pacific region is estimated to be the contrast agents market’s fastest-growing region due to the growing fractures, spinal problems, and health issues among the geriatric population. Here, it shows that the increasing patient pool is growing the medical imaging demands among the population and enhancing the global market growth in the region. Further, the Middle East & African region is predicted to generate very little of the market shares. However, this region might drive the growth of the Contrast Media Market for the upcoming years due to the increasing number of hospitals, diagnostic centers, and clinics in the region.
Global Contrast Media Market Share (%), by Region, 2018 
Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports
Contrast Media Market Competitive Landscape Analysis
The Contrast Media Market has significant major players across various parts of the countries. These significant key players are:
- Bayer AG (Germany),
- Bracco Diagnostic Inc. (US),
- DAIICHI (Japan),
- NANOSCAN IMAGING (US),
- Jodas Expoim (India),
- GE Healthcare (US),
- Guerbet Group (France),
- Lantheus Medical Imaging Inc. (US),
- Taejoon Pharm (Korea),
- Magnus Health (US),
- Spago Nanomedical AB (Germany).
These contrast media companies are the pillar of the global contrast media market. These key players are creating better outcomes by implying different marketing strategies and methods.
Recent Developments
- In 2019, the American Cancer Society, Inc had predicted that 1,762,450 people in the US would be diagnosed with cancer. Hence, it shows the increasing contrast media market growth with huge cancer diagnosed patients.
- From December 2016 to November 2017, the National Health Service (NHS) England has published a report on the diagnostic imaging dataset where 41.4 million imaging tests were reported in the region. Out of all, 1.87 million are plain radiography (X-ray), and rests are ultrasound, diagnostic ultrasonography, magnetic resonance imaging, and computerized axial tomography.
Report Overview
The contrast media injectors market report is comprised of both qualitative and quantitative analysis to understand the performance of the Contrast Media Industry. Here, the report has given the focus on the market revenue, market size, and market value to understand the present growth aspects of the global market. Along with that, the report has also given an overview of the COVID-19 situation to understand the positive and negative impact of the pandemic on the global market.
Further, the report has given emphasis on the market segmentation, market overview, and market dynamics to explain the details of the current challenges, restraints, competitions, and growth of the global Contrast Media Industry.
Segmental Table:
By Type:
- Gadolinium-based contrast media
- Iodinated contrast media
- Barium-based contrast media
- Microbubble contrast media
By Form:
- Liquid
- Tablet
- Powder
- Paste
By Procedures:
- Magnetic resonance imaging (MRI)
- X-ray or computed tomography (CT)
- Ultrasound
- Others
By Applications:
- Oncology
- Cardiovascular disease
- Neurological disorders
- Gastrointestinal disorders
- Other indications
By Route of Administration:
- Injectable
- Rectal
- Oral
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | Significant Value |
| CAGR | 3.5% CAGR (2019-2025) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Form, Procedures, Application and Route of Administration, |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | DAIICHI (Japan), NANOSCAN IMAGING (US), Bayer AG (Germany), Bracco Diagnostic Inc. (US), GE Healthcare (US), Guerbet Group (France), Jodas Expoim (India), Lantheus Medical Imaging Inc. (US), Magnus Health (US), Spago Nanomedical AB (Germany), and Taejoon Pharm (Korea) |
| Key Market Opportunities | Demand for improved diagnostic imaging services and various diagnostic imaging modalities are creating substantial market demand. |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The global contrast media market had reached to a valuation of USD 4.96 BN in 2018.
The global contrast media market is estimated to grow at 3.5% CAGR during the forecast period (2017-2023).
Increasing prevalence of chronic diseases and accident cases,
North America holds the largest share in the global contrast media market followed by Europe and Asia Pacific, respectively.
Daiichi (Japan), GE Healthcare (US), Bayer Healthcare Pharmaceuticals (Germany), NanoScan Imaging (US), AMAG Pharmaceuticals (US), Medrad Inc. (US), Guerbet (Japan), Targeson (US), Bracco Diagnostic Inc. (Italy), Covidien (Ireland), Guerbet Group (France), Lantheus Medical Imaging (U.S.), Subhra Pharma Private Limited (India), Bracco Imaging S.p.A. (Italy), nanoPET Pharma GmbH (Germany), Mallinckrodt Pharmaceuticals (UK), and CMC Contrast AB (Sweden), are some of the major players operating in the global contrast media market.
